Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Abstract P22: PVR (CD155) epigenetic status mediates adoptive cell therapy and anti-TIGIT response in Multiple Myeloma
Laura Martinez‐Verbo, Lorea Villanueva, Pere Llinàs‐Arias, Carlos A. García‐Prieto, David Piñeyro, Aina Oliver‐Cáldes, Almudena García-Ortiz, Antonio Valeri, Carlos Fernández de Larrea, Joaquín Martínez‐López, Gerardo Ferrer, Manel Esteller (2024). Abstract P22: PVR (CD155) epigenetic status mediates adoptive cell therapy and anti-TIGIT response in Multiple Myeloma. , 5(2_Supplement), DOI: https://doi.org/10.1158/2643-3249.bcdsymp24-p22.
Article303 days agoPVR (CD155) epigenetic status mediates immunotherapy response in multiple myeloma
Laura Martinez‐Verbo, Yoana Veselinova, Pere Llinàs‐Arias, Carlos A. García‐Prieto, Aleix Noguera‐Castells, Miguel L. Pato, Alberto Bueno-Costa, Ignacio Campillo‐Marcos, Lorea Villanueva, Aina Oliver‐Cáldes, Oriol Cardús, Sergi V. Salsench, Almudena García-Ortiz, Antonio Valeri, Elizabeta A. Rojas, Naroa Barrena, Norma C. Gutiérrez, Felipe Prósper, Xabier Agirre, Carlos Fernández de Larrea, Joaquín Martínez‐López, Gerardo Ferrer, Manel Esteller (2024). PVR (CD155) epigenetic status mediates immunotherapy response in multiple myeloma. , 38(12), DOI: https://doi.org/10.1038/s41375-024-02419-z.
Article303 days agoP822: EPIGENETIC REGULATION OF CD155 ON MULTIPLE MYELOMA CELLS INFLUENCES ANTI-TUMOR NOVEL IMMUNOTHERAPEUTIC APPROACHES
Laura Martinez‐Verbo, Lorea Villanueva, Pere Llinàs‐Arias, Carlos A. García‐Prieto, David Piñeyro, Aina Oliver‐Cáldes, Almudena García-Ortiz, Antonio Valeri, Carlos Fernández de Larrea, Joaquín Martínez‐López, Gerardo Ferrer, Manel Esteller (2023). P822: EPIGENETIC REGULATION OF CD155 ON MULTIPLE MYELOMA CELLS INFLUENCES ANTI-TUMOR NOVEL IMMUNOTHERAPEUTIC APPROACHES. , 7(S3), DOI: https://doi.org/10.1097/01.hs9.0000970192.40461.5e.
Article303 days agoCD155 on Multiple Myeloma Cells Is Epigenetically Regulated, Reduce Patients Survival and Compromises the Action of Novel Immunotherapies
Laura Martinez‐Verbo, Lorea Villanueva, Pere Llinàs‐Arias, Carlos A. García‐Prieto, David Piñeyro, Aina Oliver‐Cáldes, Almudena García-Ortiz, Antonio Valeri, Carlos Fernández de Larrea, Joaquín Martínez‐López, Gerardo Ferrer, Manel Esteller (2023). CD155 on Multiple Myeloma Cells Is Epigenetically Regulated, Reduce Patients Survival and Compromises the Action of Novel Immunotherapies. , 142(Supplement 1), DOI: https://doi.org/10.1182/blood-2023-179313.
Article303 days agoSequencing BCMA‐ and GPRC5D‐targeting immunotherapies in multiple myeloma: Practical guidance from the European Myeloma Network
Niels W.C.J. van de Donk, Philippe Moreau, Jesús F. San Miguel, María‐Victoria Mateos, Meletios A Dimopoulos, Sonja Zweegman, Francesca Gay, Monika Engelhardt, Roberto Mina, Elena Zamagni, Michel Delforge, Meral Beksaç, Andrew Spencer, Fredrik Schjesvold, Christoph Driessen, Martin Kaiser, Aurore Perrot, Ralph Wäsch, Charlotte L.B.M. Korst, Annemiek Broijl, Cyrille Touzeau, Salomon Manier, Roman Hájek, Jelena Bila, Güldane Cengiz Seval, Michael O’Dwyer, Heinz Ludwig, Carlos Fernández de Larrea, Rakesh Popat, Pellegrino Musto, Paula Rodríguez‐Otero, Kwee Yong, K. Martin Kortüm, Leo Rasche, Evangelos Terpos, Marc S. Raab, Mario Boccadoro, Pieter Sonneveld, Hermann Einsele (2025). Sequencing BCMA‐ and GPRC5D‐targeting immunotherapies in multiple myeloma: Practical guidance from the European Myeloma Network. , 9(11), DOI: https://doi.org/10.1002/hem3.70260.
Article36 days ago